DIFFERENTIATION AND PROLIFERATION OF EMBRYONIC MAST CELLS OF THE RAT by Combs, J. W. et al.
DIFFERENTIATION  AND  PROLIFERATION 
OF EMBRYONIC  MAST  CELLS  OF THE RAT 
J.  W. COMBS,  M.D.,  D.  LAGUNOFF,  M.D.,  and E. P.  BENDITT  M.D., 
From the Department of Pathology, University of Washington School of Medicine, Seattle 
ABSTRACT 
Histochemical reactions and radioautography were used to investigate the sequence of mast 
cell development in rat embryos. Mast cells arise ubiquitously in and are confined to the 
loose connective tissue in the embryo. The alcian blue--safranin reaction distinguishes be- 
tween weakly sulfated  and  strongly sulfated mucopolysaccharides by a  shift from  alcian 
blue  to  safranin  staining.  Based  on  this  reaction  and  morphologic  characteristics,  four 
stages were identified. Stage I  mast cells are lymphocyte-like cells with cytoplasmic gran- 
ules which invariably stain blue with the alcian blue-safranin reaction.  In Stage II cells 
the majority of granules are alcian blue-positive, but some safranin-positive granules have 
appeared.  Stage III mast cells are distinguished by a  majority of safranin-positive cyto- 
plasmic granules; some  alcian blue-posltive granules still remain.  Stage IV cells contain 
only safranin-positive granules. Thymidine-H  3 uptake and identification of mitotic figures 
indicates that mast cells in Stages I  and II comprise a mitotic pool while those in Stages 
III and IV are mitotically inactive. The pattern of $3~)4 incorporation and  the sequence 
of appearance of histochemically identifiable mast cell constituents corroborates division of 
the proliferation and differentiation of embryonic mast cells into the four stages described 
above. The process of formation of mast cell granules is interpreted as reflecting the syn- 
thesis and accumulation of a heparin precursor in alcian blue positive granules followed by 
the synthesis and accumulation of highly N-sulfated heparin along with mast cell chymase 
and finally histamine in safranin-positive granules. 
INTRODUCTION 
Mast  cells  are  common  elements  of connective 
tissue in almost every vertebrate species examined. 
Historically  the  distinguishing  characteristic  of 
the  mast  cell  has  been  its  metachromatic  cyto- 
plasmic granules.  Partial analysis and  identifica- 
tion of the components of the granules have only 
been  achieved in  the past 30  years. The  typical 
granules  are  now  known  to  contain  heparin, 
histamine,  and  an  alkaline  active  protease  or 
proteases; in  two  species 5-hydroxytryptamine is 
also  a  constituent  of the  granule.  A  systematic 
and comprehensive endeavor to study the source, 
mode of increase in  numbers  and  differentiation 
of  mast  cells  was  made  by  Maximow  and  his 
associates between  1907  and  1924  (1,  9,  10,  28- 
30). Since then only partial and sporadic attempts 
have  been  made  to  characterize these processes. 
Usually this has  been  done  in  young  and  adult 
mammals by examining mitotic activity of typical 
mast cells with efforts to distinguish differentiation 
from some precursor cell type (2, 4, 8, 33-35, 39, 
40).  The  availability of methods  for  the  histo- 
chemical demonstration of heparin (37), histamine 
(21), and the characteristic proteases (19) coupled 
with  the  ability  to  examine  specific  chemical 
groups  and  the  mitotic  activity  of  cells  with 
$77 radioisotope-labeled  compounds  provided  the 
basis for a  new survey of the problem. 
METHODS  AND  MATERIALS 
Embryos of Sprague-Dawley rats were collected either 
by surgical removal or following sacrifice of pregnant 
females  under  light  ether  anesthesia.  Animals were 
killed  postnatally  by  exsanguination  under  light 
ether anesthesia. Agc was measured from the day on 
which  sperm  were  observed  in  the  vaginal  smear 
(25) ; crown-rump length was used in some instances 
for  assessing age utilizing the established correlation 
between this length and age (11). 
The  histochemical  procedures  and  compounds 
employed  with radioautography  are  listed in Table 
I.  Tissues for the periodic acid-Schiff (PAS),  diazo- 
tized p-bromoaniline (PBA)  and phenyl proprionyl- 
naphthol-AS  (PPNAS)  reactions were  quenched  in 
isopentane-propane  solution  at  -- 190°C,  freeze- 
dried,  fixed  in formaldehyde vapor  for  48  hours  at 
60°C  (21),  embedded  in  10  per cent piccolyte-par- 
aft:in,  and sectioned  at  5/~.  For  other staining pro- 
cedures, tissues were fixed at least 24 hours in 10 per 
cent neutral buffered formalin at 0°C, dehydrated in 
graded  ethanol-water  solutions  and  chloroform, 
cleared in xylene, embedded in 10 per cent piccolyte- 
paraffin, and sectioned at 5 #. 
SuO4,  3.0  /2c per gram body weight,  or tritiated 
thymidine,  0.7  /~c  per  gram  body  weight,  was  ad- 
ministered  to  pregnant rats via  tail  vein.  The  time 
intervals prior  to  sacrifice  were  48  hours  for  S~504 
and  20  minutes,  2,  4,  8,  12,  24,  48,  and 120  hours 
for tritiated thymidine. Tissue sections were mounted 
on glass slides and coated with NTB-3 photographic 
emulsion  (Eastman  Kodak,  Lot  LSD  3-8-2).  The 
coated slides were exposed for  14 days,  developed in 
Dektol  and  the  emulsion fixed  in Kodak  acid  fixer 
followed by  10 minutes in 10 per cent formalin. The 
alcian  blue~safranin  reaction  was  utilized  to  stain 
the radioautographs.  It was  necessary to  adjust  the 
staining  time  in  safranin  to  yield  the  same  differ- 
ential  staining characteristics observed  in  uncoated 
sections. 
OBSERVATIONS 
Differentiation 
STAGES OF DIFFERENTIATION 
Sections  in  each series of embryos studied  were 
stained  with  toluidine  blue  for  the  identification 
of mast cell granules, and the alcian blue-safranin 
staining reaction was used to differentiate strongly 
sulfated  from  unsulfated  or"  partially  sulfated 
mucopolysaccharides  (15,  37).  A  combination  of 
morphologic characteristics and staining properties 
with the alcian blue-safranin procedure permitted 
a  division  of the  apparently  continuous  develop- 
ment  of  the  mast  cell  into  four  arbitrary  stages 
(Table II). 
Stage I  cells  are  round  embryonic  lymphocyte- 
like cells distinguishable from other mesenchymal 
ceils only by the presence of a variable number of 
cytoplasmic  granules which invariably stain  blue 
with the alcian blue-safranin reaction and display 
a  color  intermediate  between  orthochromatic 
blue and metachromatic red-purple when stained 
with  toluidine  blue.  The  number  of  granules 
ranges from one or two scattered in the basophilic 
cytoplasm of the youngest cells of this stage  to  a 
number sufficient to crowd the cytoplasm (Fig. 3). 
Stage H  mast cells have scant, highly basophilic 
cytoplasm with granules which stain with safranin 
(after alcian blue) in numbers varying from a  few 
to  about half the number present in  a  given cell. 
Some granules show  definite metachromasia with 
toluidine blue (Fig. 4). 
Stage  III mast  ceils  are  packed  with  granules. 
The  majority  of  the  granules  stain  red  with  the 
TABLE  I 
Specific Methods 
Substance or property demonstrated  Method 
Acidic mucopolysaccharides  (36) 
Acidic mucopolysaccharides  (37) 
Polysaecharides  (31) 
Nuclear morphology  (38) 
Histamine  (21) 
Chymotrypsin-like enzyme  (18) 
SO4 incorporation into heparin  (20) 
Mitotic activity  (4,  24) 
Toluidine blue,  pH 3.5 
Alcian bluc-safranin,  pH  1.0 
Periodic acid-Schiff (PAS) 
Feulgen-methylene green 
Diazotized p-bromoaniline  (PBA) 
Phenyl proprionyl naphthol-AS  (PPNAS) 
$3504 
Tritiated thymidine 
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alcian  blue-safranin  procedure  and  metachro- 
maticaUy with toluidine blue (Fig. 5). 
Stage IV is the fully mature stage.  The cells are 
large  and  their  relatively small nuclei are  often 
obscured by the tightly packed granules which are 
brilliantly  metachromatic  with  toluidine  blue. 
With  the  alcian  blue-safranin reaction  all  the 
granules  are  stained  metachromatc  brick  red 
(Fig. 6). 
NUCLEAR CHARACTERISTICS  BY STAGE 
The Fculgen reaction as modified by Swift (38) 
was  employed  to  study  the  morphology  of  the 
mast  cell  nuclei in sections from  a  21  day  old 
TJ  embryo  and  adult  tongue.  Methylene  green,  a 
nitrated  analog  of  methylene  blue  (14),  was 
utilized as a counterstain in 0.1  per cent aqueous 
solution adjusted to pH 3.5 with acetic acid. This 
•  ~  stain is green in the orthochromatic and blue in 
the metachromatic state, allowing positive identi- 
fication  of  mast  cells  with  a  color  contrasting 
v  °  sharply with the magenta  of  the  Feulgen-Schiff 
reaction. 
q  Stage I  and II mast cell nuclei varied consider- 
-o  ably in size and morphologic detail. Since all the 
mitotic nuclei observed in the  embryo appeared 
•  g  to fall in these stages, more variation in chromatin 
o 
particle size  and  dispersion pattern was  seen  in 
"~  Stages  I  and II than in later stages.  The typical 
_"  Stage I  and II interphase nucleus was spherical, 
often  lacked  a  definite  nucleolus and  had  fine 
~v  homogeneously  dispersed  chromatin  with  the 
exception  of  occasional  peripheral  chromatin 
clumps (Fig.  7).  Stage  III mast cells  had  nuclei 
O 
-g  which resembled the nuclei in surrounding mesen- 
chymal  cells.  Often  eliptical or  kidney shaped, 
these nuclei uniformly had one or two well defined 
nucleoli, moderately clumped chromatin,  and  a 
°v  clearly  demarcated  nuclear  envelope  (Fig.  8). 
ho 
The mature mast cell nucleus was  poorly delin- 
eated  by the  Feulgen-Schiff procedure,  and  the  >. 
-~  usual  metachromatic  dyes  used  as  identifying 
counterstains tended  to  obscure  the  nucleus by 
intense staining of the cytoplasmic granules. How- 
¢J 
ever,  morphologic  detail  in  Stage  IV  nuclei 
became evident in alcian blue-safranin prepara- 
tions following the nitrous acid hydrolysis proce- 
dure  described  below.  Stage  IV  nuclei  were 
eliptical with large chromatin clumps abutting on 
the  nuclear  envelope  and  a  centrally  placed 
chromatin  mass  reminiscent of  the  "cartwheel" 
nucleus of the plasma cell (Fig. 9). 
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HEPARIN :  The pattern of alcian blue--safranin 
staining of the heparin and/or heparin precursors 
of mast cell granules was outlined above. In order 
to  clarify  the  results  of the  alcian  blue-safranin 
staining  reaction,  hydrolysis  designed  to  liberate 
sulfamido sulfate was performed on the tissue sec- 
tions using nitrous  acid  (23).  Hydrolyzed sections 
were  stained  simultaneously  with  sections  pre- 
treated  with  5  per cent  acetic  acid  and  with un- 
treated  sections.  Hydrolysis  for  60  minutes  or 
longer  at  room  temperature  with  dilute  nitrous 
acid  1 regularly  abolished  the  affinity for safranin 
and  the toluidine  blue metachromasia  of mature 
mast  cell granules,  Evidence for the specificity of 
the nitrous acid reaction was seen in the fact that 
this treatment did not affect the safranin  staining 
or the toluidine blue metachromasia of chondroi- 
tin  sulfate-rich  embryonic  cartilage. 
The  significance  of the  PAS  reaction  in  mast 
cells  was  obscured  by  the  finding  that  mature 
mast  cell granules reacted  positively with  Schiff's 
reagent  without  prior  periodic  acid  hydrolysis 
after freeze-drying and vapor fixation. The direct 
Schiff reaction first became positive in embryonic 
Stage  III  mast  cells  at  about  19  or  20  days,  so 
that  data  for the  PAS  reactivity of the mast  cell 
were  able to  be interpreted  only in  Stages  I  and 
II.  The  first  PAS  positive  cells  morphologically 
like mast  cells were seen in  the region of the de- 
veloping  spinal  column  at  about  16  days  with 
both  cytoplasm  and  granules  staining.  Cells cor- 
responding  to  Stage  I  stained  less intensely  than 
those of Stage II. 
Sulfate  incorporation  into  the  heparin  and 
heparin precursors in mast cells was measured  by 
radiosulfate  uptake  (5,  20).  A  series  of embryos 
was  examined  after  administration  of $3504  and 
included  embryos  of  approximately  19,  22,  and 
24 days postconception  from three pregnant  rats, 
with  tongue  and  dorsal  skin  from the  hind  paws 
of the adult animals as control tissues. The average 
level of labeling of the mast  ceils in  adult tongue 
was  assigned  a  value of  1 +  and  the intensity  of 
cellular labeling was graded  from 0  to 4 +  (Figs. 
12  through  15).  The  sections  were  stained  with 
the alcian blue-safranin reaction, and the intensity 
of labeling of each cell correlated with its matura- 
tional stage.  The results  of these experiments  are 
given in Table III. 
10.05  per cent NaNO~  +  0.33  per cent  acetic acid 
in equal parts. 
TABLE  III 
S~04 Incorporation of Mast Cells 
According to Stage 
Expressed  as per cent of cells in each stage 
at  the  indicated  level of intensity  of labeling 
based  on  the  average  labeling  of  Stage  IV 
mast cells taken as 1 +, 2+  equal to twice the 
labeling  intensity  of stage  IV,  etc.  See Figs. 
10  to  13.  Values  obtained  from one  thousand 
consecutively counted Stage I, II and III mast 
cells in hind limbs of two newborn rats from the 
same  litter  (crown-rump  ca. 45  ram)  and  100 
consecutively counted  Stage  IV mast  cells in 
adult  tongue  and  dorsal  foot  skin. 
Intensity of label 
No. of 
Stage  mast cells  -[-  --}--}-  --}--I-+  -]-@++ 
I  182  40  52  8  0  0 
II  338  1  22  44  32  1 
III  480  1  1  9  66  24 
IV  100  27  73  0  0  0 
HISTAMINE :  The  diazotized  para-bromoani- 
line  reaction  for  histamine  was  first  positive  in 
Stage IV mast cells at the time of birth  (21  to 22 
days  postconception)  and  increased  in  intensity 
to a  maximum by about the 33rd postnatal  day. 
MAST  CELL  PROTEASE:  The  characteristics 
of a  protease with chymase-like activity present in 
rat  mast  cell  granules  have  been  reviewed  by 
Lagunoff  and  Benditt  (19).  When  the  phenyl- 
proprionate  ester of naphthol  AS was used  as the 
histochemical substrate  for this  enzyme in  a  lim- 
ited series of embryos ranging from  15  to 26 days 
in age,  a  positive reaction was first observed at  17 
days  with  little  change  in  intensity  in  later  em- 
bryos. As these preparations could not be counter- 
stained  satisfactorily,  the  stage  of  the  earliest 
PPNAS-positive  cells  was  difficult  to  assess,  but 
must  be  Stage  I  and/or  II,  since  Stage  III  and 
IV mast ceils had not yet appeared  at the  17-day 
level of embryonic development. 
Proliferation 
EARLY DISTRIBUTION:  Stage  I  mast  cells 
were first seen in head mesenchyme ventral to the 
developing brain  in  embryos of about  15  days of 
age. The early mast cell population of the embryo 
increased  rapidly  in  number,  and  Stage  II  cells 
appeared  in  developing  loose  connective  tissue 
around  the dorsal vertebrae  on the  16th  day.  At 
18  or  19  days  post-conception,  Stage  III  cells 
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Mast Cell Stage  versus Crown-Rump 
Length  and Age 
Values  represent  per cent  of  cells  in  each 
stage  based  on  one  hundred  consecutively 
counted  mast  cells  in  subcutaneous  mesen- 
chyme  in  one  parasagittal  section  from  one 
embryo  at  each  indicated  age/length. 
Crown-rump length in mm 
16.5  25  28  32  39  45 
Age in days 
Stage  16  18  19  20  22  23 
I  93  50  42  34  23  21 
I I  7  38  47  50  50  33 
III  0  12  11  16  27  41 
IV  0  0  0  0  0  5 
became  evident  generally  in  subcutaneous  con- 
nective  tissue,  but  cells  of  Stage  IV  were  not 
present until just prior to birth  (Table IV). 
UlTOTIC  COUNTS:  Utilizing  the  Feulgen- 
Schiff reaction with methylene green counterstain 
described  above,  sections  from  a  twenty-one  day 
old  embryo  and  adult  tongue  were  examined for 
morphologic  evidence  of mitotic  activity.  Nuclei 
of Stage  I  and  II  mast  cells were  found  in  each 
stage  of  mitosis  except  the  telophase  (Fig.  11). 
Binucleate  and  daughter  ceils  were  also  seen  in 
embryonic  tissue;  however,  no  mitotic  nuclei  or 
binucleate  ceils  were  observed  in  mast  cells  in 
adult  tissue.  In  the  results  presented  in  Table 
V, only clearly  identifiable  nuclei  were  included 
in the mitotic group.  Prophase  and reconstruction 
phase  nuclei  were  included  as  a  single  category 
since no clear distinction could be made between 
them. The "Dot identified" category includes mast 
ceils whose  nuclei  were  obscured  by  granules  or 
were otherwise  unable  to  be unclassified. 
TRITIATED  THYMIDINE :  Embryos ranging 
from  16  to 25  days postconception were collected 
from  12  pregnant  females  at  the  time  intervals 
specified  above  after  tritiated  thymidlne  admin- 
istration;  adult  tongue  and  duodenum  were used 
as  control  tissues.  Mast  cells  were  identified  as 
either labeled or unlabeled (Fig.  10). A substantial 
proportion  of  mast  ceils  in  the  embryo  actively 
incorporated  tritiated  thymidine  into  the  nucleus 
but  the  extent  of incorporation  varied  with  the 
stage  of  the  cell  and  the  time  interval  between 
administration  of  the  single  dose  of  thymidine 
and  sacrifice.  Stage  I  and  II  cells  incorporated 
thymidine  most  rapidly;  cells  in  Stages  III  and 
IV exhibited marked  delay in  the  appearance  of 
label  in  their  nuclei.  Mast  cells in  adult  control 
tissues  did  not incorporate  tritiated  thymidine  in 
detectable  quantities  under  the  conditions  used. 
No label was seen in tissues from embryos sacrificed 
20  minutes  after  administration  of thymidine  to 
pregnant  rats,  even  though  mitotically  active 
maternal  tissue  such  as  gastrointestinal  mucosa 
was well labeled in this interval; tissues of embryos 
collected from the same pregnant  female after an 
interval  of  12  hours  also  showed  radioactivity. 
The  results  of  the  thymldine  incorporation  are 
summarized in Table VI  and  Fig.  1. 
DISCUSSION 
Proliferation 
The first recognizable mast cells of the rat em- 
bryo  arise  in  the  head  mesenchyme  near  the 
ventral  portion  of the  developing brain  at  about 
15  days  postconception.  The  number  of  mast 
cells increases reaching a  maximum in the 2  days 
just  prior  to  birth,  with  those  in  the deep  (more 
axial)  connective  tissue  appearing  last.  In  the 
newborn rat the distribution of the mast cell popu- 
TABLE  V 
Mitotic Activity in Mast Cells  Observed with the Feulgen-Methylene  Green Technique* 
Values  obtained  from 1103 consecutively counted  mast  cells with visible nuclei in the hind  limb 
of 21  day rat embryo. 
Prophase- 
reconstruction  Binucleate  Daughter 
Not identified Interphase  phase  IVfetaphase  Anaphase  Telophase  cells  cells 
Number  276  702  101  3  4  0  10  7 
Per cent  25  63.6  9.2  0.27  0.36  0  0.91  0.63 
* cf. text, page 579. 
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lation is similar to that in the mature rat, but the 
number of mast cells per unit volume of connec- 
tive tissue is much higher.  Cells in all of the pro- 
posed stages are evident in the newborn, whereas 
only Stage IV mast cells are observed in normal 
adult tissues. Our studies thus confirm the findings 
of Maximow (28-30) and his associates Danchakoff 
(9)  and Alfejew (1)  in the time of appearance of 
mast  cells  recognizable  by  their  metachromatic 
granules  and  in  the  distribution of these  cells in 
the embryo. The earliest identifiable mast cells in 
Stage  I  have  relatively large  nuclei infrequently 
displaying  nucleoli,  with  finely  divided  and 
disperse  chromatin  and  a  narrow  rim  of  clear 
basophilic cytoplasm  containing  several  discrete 
alcian  blue-positive  granules  (Figs.  3  and  7). 
Except for the presence of specific granules, these 
cells resemble the large lymphocyte described by 
Maximow (28). 
In  the  studies of the  incorporation  of thymi- 
dine-H  3 into mast cells 2  hours  after  administra- 
tion of a single dose, 20 per cent to 30 per cent of 
Stage I  and II cells were labeled. Since the total 
number of mast cells in Stages I  and II increases 
rapidly in embryonic connective tissue during the 
labeling intervals studied, it is plausible to assume 
that the high rate of incorporation of thymidine-H  ~ 
indicates mitotic activity in  Stage  I  and  II mast 
cells.  Precursor  cells  also  presumably  proliferate 
mitotically, and would  increase the  apparent in- 
corporation rates of Stage I  and II, the magnitude 
of their  contribution  depending on  the  rapidity 
with which they develop recognizable cytoplasmic 
granules.  The  alternative  possibility,  that  only 
mitotically  active  precursor  cells  incorporate 
thymidine into  newly formed DNA,  divide,  and 
synthesize mast cell granules in a period of 2 hours 
in  sufficient  number  to  give up  to  30  per  cent 
labeling of the Stage I  and  II cells, is highly un- 
likely. The delayed labeling of Stages III and IV 
and  the  reduction  in  the  proportion  of  labeled 
cells in  Stages I  and  II during the  period when 
the  proportion of labeled cells in  Stages III and 
IV is rising, is consistent with a sequence of matu- 
ration  from  mitotically  active  Stages  I  and  II 
to mitotically inactive Stages III and IV. Accord- 
ingly,  the  embryonic  mast  cell  population  is 
divisible  into  mitotic,  maturational,  and  end- 
stage subpopulafions: Stage I and II cells comprise 
a mitotic pool; Stage III cells comprise the matu- 
rational pool and attain the end-stage of develop- 
ment  (Stage  IV)  without  significant intervening 
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rule  out  the  possibility of  mitosis  occurring  at 
some  low  rate  in  Stage  IV  cells;  however,  the 
rapid relative and absolute increase in the  mast 
cell population accompanied by the maturational 
shift  described  above  (Table IV)  indicates that 
the contribution of mitosis in Stage IV cells, if it 
occurs,  would  be  small  in  comparison  to  the 
number of Stage  IV cells  arising by maturation 
from  Stage  III.  If in fact  no mitosis occurs  in 
Stages  III and IV, the arrival in Stage IV of the 
most  rapidly  maturing  labeled  Stage  II  cells 
and/or  incorporation  of  thymidine-H  3  without 
mitotic activity as  discussed  below may account 
for the 3 per cent labeling observed in Stage IV at 
12 and 24 hours following dosage (Table VI). This 
scheme is presented diagrammatically in Fig. 2. 
Pelc  (32)  divides  cells  incorporating tritiated 
thymidine at rates detectable in our experiments 
into two  "metabolic stages,"  those incorporating 
thymidine at  rates  indicating doubling of DNA 
with  subsequent  mitotic  division,  and  cells  in- 
corporating thymidine at comparable rates with- 
out subsequent mitotic division. He further  sug- 
gests that in certain cell populations incorporation 
of thymidine largely represents DNA synthesis in 
non-dividing cells,  leading  to  a  high  value  for 
the  ratio  of  the  per  cent  labeled  nuclei to  the 
mitotic index, whereas in cell populations incor- 
porating thymidine with subsequent cell division, 
this ratio has  a value in the range of 15 or less. 
Although  other  investigators  report  that  some 
mast cells in adult rodents incorporate thymidine, 
the incidence of these cells is low (2, 4, 40). Allen 
has  presented  information obtained with  young 
rats (30 days) for which the percentage of labeled 
cells and the mitotic index give a ratio of 10 which 
is in the range of a mitotically active population 
(3).  In our study, the mitotic index derived from 
data presented in Table IV, assuming that 50 per 
cent of the cells in the category labeled "Prophase- 
Reconstruction Phase"  are in prophase, is slightly 
greater than 5  per cent. All of the mitoses  were 
observed in Stage I or II cells. Since approximately 
20  to  30  per  cent  of  Stage  I  and  II  cells  was 
labeled  at  the  maximum incorporation interval, 
the ratio of mitotic index of embryonic mast cells 
to the per cent of labeled cells in the mitotic popula- 
tion  is  approximately  5;  this  is  consistent with 
DNA synthesis leading to mitosis.  The observation 
of mitotic figures  in Stage I  and II cells  directly 
confirms the occurrence of mitosis in these stages 
(Fig.  11). The population of mast cells in young 
rats  and  those  experimentally stimulated  mast 
cells (4) in older rats which undergo mitosis could 
well correspond to a  pool of immature cells com- 
parable to the Stage I  and II cells of the embryo. 
The mast cells of the adult may also largely come 
from such a reservoir. 
Differentiation 
Heparin is known to be present in high concen- 
tration in mast cells  (7,  17)  and is responsible for 
the  characteristic  metachromatic  staining of the 
granules. The presence of metachromatic granules, 
although  not  entirely  sufficient  to  identify  the 
cell, is  an invariable characteristic of mast cells. 
Thus the  synthesis of heparin or  an  identifiable 
heparin precursor may be taken as the biochemical 
event that marks off the  mast cell from its pre- 
cursor. The metachromasia of heparin depends on 
the  presence  of  a  high  concentration of  acidic 
sulfate  groups  distributed  along  the  polymeric 
chain (6,  36).  The sulfates  in the case  of heparin 
are present both as  sulfamido groups and as the 
more common sulfate esters (12). Spicer has postu- 
lated that the alcian blue-safranin reaction differ- 
entiates  degrees  of  sulfation,  the  more  highly 
sulfated the polysaccharide, the greater its affinity 
for safranin (37).  Since nitrous acid hydrolysis is 
known  to  selectively  remove  sulfamido  sulfate 
from  heparin  (23)  and  nitrous  acid  abolishes 
safranin staining of mast cell granules but does not 
alter  the  safranin staining of the  N-sulfate  poor 
polysaccharides  of  cartilage,  some  confidence is 
placed in the histochemical selectivity of this treat- 
ment  sequence.  It  is  proposed  then  that  those 
mast cells  having safranin-negative, alcian blue- 
positive  granules  (Stages  I,  II,  III)  contain  a 
polysaccharide poor or totally lacking in N-sulfate, 
presumably a heparin precursor. This polysaccha- 
ride could also be responsible for the bonafide PAS 
staining seen in the early stages of mast cell differ- 
entiation.  Similarly, those  cells  having safranin- 
positive granules contain highly N-sulfated poly- 
saccharide, probably chemically mature heparin. 
Labeling of mast cells with radiosulfate in the 
rat embryo (13)  and in adult tissues  (13,  20,  26, 
27) has previously been described. $3~O  4 incorpo- 
ration  may  represent  either  sulfation  of  newly 
synthesized  heparin  or  merely  the  turnover  of 
labile  sulfate  in  preformed  heparin.  There  is  a 
striking difference between the moderate labeling 
of  embryonic  Stage  II,  the  intense  labeling of 
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in Stage I  and adult mast cells  (Figs.  12 through 
15).  This  is  taken  as  indicating a  high  rate  of 
heparin  synthesis  in  the  Stage  II  and  III  cell 
population, consistent with the increasing number 
of granules present in these cells and the increasing 
proportion of granules which stain with  safranin 
in the AB-S staining sequence. 
The  appearance  of  chymase  activity  in  em- 
bryonic cells at a time when only those cells con- 
sidered to be immature mast cells  are present in 
the em*bryo on the one hand confirms the identifi- 
cation of these cells, and on the other hand demon- 
strates that  this enzyme is present in the  cell at 
essentially  maximal  concentration  during  the 
process  of  active  heparin  synthesis.  The  early 
appearance  of  this  enzyme  is  consistent  with 
evidence that the enzyme constitutes a significant 
part of the granule matrix (5, 22). This is in con- 
trast to the situation with respect to histamine, as 
histamine does  not become evident in embryonic 
mast cells until after the appearance of N-sulfated 
mucopolysaccharide and is very slow in reaching 
maximal  levels.  Although  the  determination of 
precisely when  histamine is first  bound in mast 
cells  is  limited by  the  sensitivity of the  method 
employed, the  difference between the concentra- 
tions  of  chymase  and  histamine relative  to  the 
maximal concentration of each in adult mast cells 
is  indicative of  different  maturational  patterns. 
Based  on  the  data  presented,  the  process  of 
granule maturation can  be  tentatively analyzed 
in terms of histochemical landmarks and incorpo- 
ration of radioisotope-labeled compounds. Gran- 
ules  containing  alcian  blue-positive  material 
giving a  valid PAS  reaction and failing to  bind 
safranin are  present in cells  of Stages  I,  II,  and 
III.  These  characteristics  of  the  granules prob- 
ably indicate the synthesis and storage of a heparin 
precursor. The low level of Sn504 incorporation in 
the alcian blue-positive granules of Stage  I  mast 
cells strengthens this interpretation. Granules con- 
taining material which binds safranin appear  in 
Stage II, increase in numbers through Stage III, 
and  become  metachromatic  with  safranin  in 
Stage IV. This pattern, along with the increasing 
$3~O4 incorporation in Stage II, III, and IV cells, 
may indicate the  synthesis and  accumulation of 
highly N-sulfated heparin in the safranin positive 
granules. 
The presence of chymase during Stages  II and 
III would  allow  the  interaction of heparin  and 
this enzyme to form part or all of the framework 
around  which  the  mature  mast  cell  granule  is 
organized. Recent evidence (5, 22) favors the con- 
cept  that  histamine is  associated  with  the  mast 
cell  granule by  relatively weak  physicochemical 
forces. Its late appearance in the mast cell granule 
may indicate that the chemical scaffolding of the 
granule must  be  completed  before  binding can 
occur. 
As is seen from the data presented above, the 
embryonic tissue mast cell arises, proliferates, and 
matures in a  manner analogous to the process  of 
granulopoiesis as  postulated  by  Maximow  (28). 
The mast cell arises  from a  relatively undifferen- 
tiated cell of mesodermal origin which cannot be 
distinguished from  other  primitive mesenchymal 
cells,  and is first  recognizable by the  appearance 
of specific cytoplasmic granules. In both mast cells 
and  granulocytes mitotic  proliferation continues 
until many cytoplasmic granules are present, but 
essentially ceases  at  a  certain point  after  which 
maturation is completed by a  process  of granule 
formation  and  morphologic  alteration.  Unlike 
the  granulocytes, mast  cells  in  embryos  do  not 
arise  in  hematopoietic  tissue  but  rather  in  the 
loose connective tissue. The end result of mast cell 
genesis  is the formation of a  mature cell popula- 
tion which has lost its proliferative capability but 
has acquired an unique functional capacity. 
This work  was supported  in part by United States 
Public Health  Service  Grant HE-03174,  Pathology 
Training Grant 2  T1  GM-100-06,  and funds from 
the  Institutional Cancer  Grant  of  the  American 
Cancer Society. 
The work was performed  while Dr.  Combs was a 
Medical Student Research  Scholar. 
The  authors  wish  to  acknowledge  the  excellent 
technical  assistance  of  Mrs.  Dawn  Bockus on  this 
project. 
Received  for publication, August 3, 1964. 
(For References, see p.  591) 
584  THE  JOURNAL  OF  CELL  BIOLO6Y  " VOLUME  ~5,  1965 5o  1 
4O 
~ 20" 
I0- 
/  Stage "rv" 
/ 
//"  ./Stage Trl 
/. y...,.." 
/.:....." 
~~  ..,'2 
I  ~.~  ..""  / 
.~'°  '":--~-  ....  ~_  __  Stage T 
/.~.  ......  /."  ......  Stoge TT 
,..-"  / 
..~.~."~  /I" 
/  f  /  t" 
e.  p 
t  t  t 
2  12  24  48  120 
Hours  following  administration  of  tritiated  thymidine 
FmURE 1  Tritiated thymidine labeling of mast cell nuclei by stage expressed as the per cent of mast cell 
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:FIGURE ~  Schematic representation of mast  cell proliferation and maturation. Immature granules are 
represented by circles, mature granules by dots. 
J.  W.  COMBS, D.  LAGUNO~, AND E.  P.  BENDITT  Embryonic Mast Cells  585 FIGURE 3  Stage I  daughter mast cells containing only a few relatively large alcian blue 
positive granules. Alcian blue-safranin stain.  )<  1400. 
Fmva~, 4  Stage II mast cell. Fig. 4 a  depicts the cell photographed with a  green filter 
(Wratten XI Filter No.  11)  allowing visualization of both red and blue granules. Fig. 4 b 
is the same cell photographed with a  strong red filter (Wratten A  Filter No.  ~5)  which 
allows only blue granules to be seen. Fig. 4 c is again the same cell photographed with a 
strong blue filter (Wratten  C5 Filter No. 47)  which allows only red granules to be seen. 
Note the greater number of blue granules represented by Fig. 4 b and the distinctly different 
location of granules in Figs. 4 b and 4 c. Alcian blue-safranin stain.  )<  1400. 
FmtmE 5  Stage III mast cell. Figs. 5 a, 5 b, and 5 c were photographed using filters as de- 
scribed for Fig. 4. In Fig. 5 a  both red and blue, in Fig. 5 b only blue, and in Fig. 5 c only 
red granules are seen. Note the greater number of red granules as represented by Fig. 5 c 
and the different distribution  of granules in Figs. 5 b and 5 c. Alcian blue-safranin stain. 
X  1400. 
FIGURE 6  Stage IV mast cell containing only red granules.  Alcian blue-safranin stain. 
X  1400. 
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Note the spherical nucleus with relatively dispersed chromatin. This nuclear morphology 
is typical of interphase nuclei of either Stage I  or Stage II mast cells.  )< 1400. 
FIGURE 8  Stage III mast cell,  Feulgen-Schiff reaction with methylene green counter- 
stain. The nucleus is ovoid with some aggregation of chromatin as compared with Fig. 7, 
and two prominent nucleoli  are present.  X  1400. 
FmURE 9  Stage IV mast cell alcian blue-safranin stain following 2 hours hydrolysis in 
dilute nitrous acid. Characteristic granules have largely disappeared revealing the nuclear 
contents. The chromatin clumps abutting the nuclear envelope and a  central chromatin 
mass give an appearance closely resembling the plasma cell nucleus.  X  1400. 
FIGURE 10  Stage I  mast cell in subcutaneous tissue of a  27 mm rat embryo. Nuclear 
labeling by tritiated thymidine four hours following administration. Alcian blue-safranin 
employed as counterstain. X  1400. 
FIOImE 11  Anaphase in a  mast cell in subcutaneous connective tissue of a 41  mm rat 
embryo. Feulgen-methylene green preparation.  )< 1400. 
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labeling is  1+  on the scale  presented in Table  V.  >(  1400. 
Fmul~E 13  Stage II mast cell $3504 radioautograph stained with alcian blue-safranin. Intensity of label- 
ing is ~+ on the scale presented in Table V.  )<  1400. 
FIGURE 14  Stage III mast cell  $3504 radioautograph stained with alcian  blue-safranin. Intensity of 
labeling is 4+ on the scale presented in Table V.  )<  1400. 
FIGURE 15  Stage IV mast cell  $3sO4 radioautograph stained with alcian  blue-safranin. Intensity of 
labeling is 1+ on the scale presented in Table V.  X  1400. 
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